TCG Crossover Management »

Arvinas Ord shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Arvinas Ord (ARVN) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Arvinas Ord

Tip: Access up to 7 years of quarterly data

All positions including Arvinas Ord held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arvinas Ord by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 1.6M 8.52

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Amylyx Pharmaceuticals Comm (AMLX)
Centessa Pharmaceuticals Adrs (CNTA)
Tango Therapeutics Comm (TNGX)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Tourmaline Bio Comm (TRML)
Dyne Therapeutics Comm (DYN)
Agios Pharmaceuticals Comm (AGIO)
Eyepoint Pharmaceuticals Comm (EYPT)
Fulcrum Therapeutics Comm (FULC)
Savara Comm (SVRA)
Rapt Therapeutics Comm (RAPT)

View all positions for TCG Crossover Management

Top funds holding Arvinas Ord

Vanguard Group
BlackRock
Logos Global Management
Pfizer
D. E. Shaw & Co
Millennium Management
State Street Corporation
Geode Capital Management
TCG Crossover Management
New Leaf Venture Partners
Morgan Stanley
Qube Research & Technologies
Acadian Asset Management
Nextech Invest
Tang Capital Management

View all funds holding Arvinas Ord